What Has Investors Spooked About These 4 Stocks Today?

A day after making mild gains on the back of Apple Inc. (NASDAQ:AAPL)’s strong earnings results, Apple supplier NXP Semiconductors NV (NASDAQ:NXPI) is sinking today after its own earnings results and more specifically, its fourth quarter guidance, spooked investors. Shares of NXP Semiconductors NV (NASDAQ:NXPI) are down by nearly 17% after the company announced last night that it expects a double-digit sales decrease, percentage-wise, in the fourth quarter due to weakening demand. The shocking guidance trumped NXP’s otherwise solid third quarter results, which came in around expectations. Revenue of $1.52 billion was slightly beneath estimates, while earnings of $1.57 per share were slightly above them. 13.10% of NXP Semiconductors NV (NASDAQ:NXPI)’s outstanding shares, valued at $3.01 billion, were held by 69 of the investors we track as of June 30, making it one of the most popular semiconductor stocks. Billionaires James Dinan, Dan Loeb, and David Tepper were among the shareholders of the Dutch company.

Lastly is ABIOMED, Inc. (NASDAQ:ABMD), which has been anything but a treat for investors this morning, being down by over 22%. The slide comes despite the medical device maker’s second quarter of fiscal year 2016 results coming in above expectations at $0.17 per share in earnings and $76.4 million in revenue, the latter up by 47% year-over-year. Revenue from ABIOMED, Inc. (NASDAQ:ABMD)’s Impella heart pump accounted for much of the firm’s revenue. Gross margins improved by 2.6 percentage points to 84.5%. ABIOMED, Inc. (NASDAQ:ABMD) also slightly raised its guidance for the full 2016 fiscal year for both its revenue and GAAP operating margins. It’s unclear what has the market so spooked at the moment, as the results appear solid from top to bottom. Investors in our database held 12.70% of ABIOMED’s shares on June 30, and were growing more bullish on the stock, with 29 holding long positions at that time compared to 23 on March 31. William Leland Edwards‘ healthcare fund Palo Alto Investors was the most bullish of those 29, owning 2.74 million shares.

Disclosure: None